Teleflex Wins FDA Breakthrough Designation for Resorbable Heart Scaffold

MT newswire2026/10/22 12:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

08:52 AM EDT, 10/22/2026 (MT Newswires) -- Teleflex (TFX) said Thursday that the FDA granted Breakthrough Device Designation to its Freesolve Resorbable Magnesium Scaffold for percutaneous coronary intervention. The device is designed to support blood vessels temporarily, with 99% of its magnesium resorbed within 12 months, it said. Teleflex said the scaffold recorded a 3.5% target lesion failure rate at four years in its BIOMAG-I study. An ongoing pivotal trial is intended to support a future US premarket approval application, Teleflex added.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs Volatility Panic Index surged to 9.57, approaching its maximum value, with the largest single-day increase ranking third in history, and the combined two-day volatility setting a new record. Historical data shows that after this index has exceeded the 9.5 threshold 15 times, the S&P 500 has seen an average three-month gain of 4.6% with a success rate of 80%. However, Goldman Sachs traders warn that forced liquidations have not yet fully cleared, and the market is still searching for a bottom, but opportunities on the other side are becoming increasingly difficult to ignore.

华尔街见闻•2026/11/07 07:31